Procainamide
Pronestyl
Class:
Antidysrhythmic Class Ia
Antidysrhythmic Class Ia
Mechanism of Action:
- Suppresses phase IV depolarization in normal ventricular muscle and Purkinje fibers, reducing automaticity of ectopic pacemakers.
- Suppresses reentry dysrhythmias by slowing intraventricular conduction.
Indications:
- Suppress PVCs refractory to Lidocaine.
- Suppress VT with a pulse refractory to Lidocaine.
- PSVTs with wide-complex tachycardia of unknown origin (drug of choise when associated with WP).
Contraindications:
- Second- and Third-Degree block.
- Torsades de Pointes.
- Lupus.
- Digitalis toxicity.
- Myasthenia gravis.
Adverse reactions:
PR, QRS, and QT widening, AV Block, cardiac arrest, hypotension, seizures.
Nausea, vomiting, reflex tachycardia, PVCs, VT, VF.
CNS depression, confusion.
PR, QRS, and QT widening, AV Block, cardiac arrest, hypotension, seizures.
Nausea, vomiting, reflex tachycardia, PVCs, VT, VF.
CNS depression, confusion.
Adult Dosage and Administration
20-30 mg/min; maximum dose is 17 mg/kg.
Maintenace infusion: 1-5 mg/min.
20-30 mg/min; maximum dose is 17 mg/kg.
Maintenace infusion: 1-5 mg/min.
🧸
Pediatric Dosage and Administration:2-6 mg/kg IV at less than 20 mg/min; maximum dose is 17 mg/kg.
Maintenace infusion: 20-80 mcg/kg/min (0.02-0.08mg/kg/min).
Duration of Action:
- Onset: 10-30 minutes.
- Peak effect: Variable.
- Duration: 3-6 hours.